Table 1.
Parameters | Group A* (n = 19) | Group B** (n = 28) | Overall (n = 47) | p-value |
---|---|---|---|---|
Age | ||||
(years), mean ± SD | 52.11 ± 14.37 | 54.89 ± 15.62 | 53.77 ± 15.04 | 0.54 |
Gender (%) | ||||
Male | 31/47 (65.96) | |||
Female | 16/47 (34.04) | |||
COVID-19 | ||||
Previously infected by COVID-19 | YES | NO | ||
Main complain (%) | ||||
Sciatica | 24/47 (51.06) | |||
Lumbalgia | 4/47 (8.51) | |||
Lumbalgia and Sciatica | 19/47 (40.43) | |||
Pain duration before treatment | ||||
(months), mean ± SD | 3.78 ± 2.14 | |||
Pre-procedure ODI | ||||
mean ± SD | 32.42 ± 8.53 | 35.64 ± 12.41 | 34.34 ± 11.01 | 0.33 |
Level of disc herniation | 0.26 | |||
L3-L4 | 1 | 1 | 2 (4.26) | |
L4-L5 | 15 | 19 | 35 (72.34) | |
L5-S1 | 4 | 8 | 12 (25.53) | |
Side of the herniation | 0.44 | |||
Left | 11 | 16 | 27 (57.44) | |
Right | 8 | 12 | 20 (42.55) | |
Disc lesion morphology | 0.29 | |||
Bulges | 1 | 1 | 2 | |
Protrusion | 10 | 16 | 26 | |
Extrusion | 8 | 11 | 19 |
L lumbar vertebra, S sacral vertebra, SD standard deviation
*Group 1: patients with history of COVID-19 infection
**Group 2: patients never affected by COVID-19